 Home > Medical News > Latest Medical News > Otsuka Pharmaceutical's anti-APRIL monoclonal antibody VIS649 applied for clinical application in China

Otsuka Pharmaceutical's anti-APRIL monoclonal antibody VIS649 applied for clinical application in China

 Last Update: 2022-04-30
 Source: Internet
 Author: User

Tags

china show

sell food home

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 8, the official website of the Center for Drug Evaluation (CDE) of the China National Medical Products Administration announced that Otsuka Pharmaceutical applied for the clinical trial application of VIS649 and was accepted

Screenshot source: CDE official website

Immunoglobulin A (IgA) nephropathy is a chronic, progressive autoimmune disease associated with progressive kidney damage and is a major cause of chronic kidney disease and renal failure

VIS649 is an anti-proliferation-inducing ligand (APRIL) mAb

According to the official website of ClinicalTrials, Otsuka Pharmaceutical is currently conducting two phase 2/3 clinical studies for VIS649, one of which is to evaluate the efficacy and safety of the drug in the treatment of patients with IgA nephropathy, and the other is open for 2/3 The label study was designed to evaluate the long-term safety, tolerability and efficacy of the drug in patients with IgA nephropathy

It is expected that this innovative anti-APRIL monoclonal antibody will progress smoothly in clinical research and bring better treatment options to patients as soon as possible

References:

[1] The official website of the Center for Drug Evaluation (CDE) of the State Food and Drug Administration of China.

[4] ClinicalTrials official website.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.